Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onder Alpdogan

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Cell Transplantation|May 17, 2006
Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cellsPhilipp Mayer-Kuckuk, Mikhail Doubrovin, Luc Bidaut, et al.
Blood|March 31, 2007
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activityChiara Borsotti, Anna R K Franklin, Sydney X Lu, et al.
Blood|November 9, 2002
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantationCornelius Schmaltz, Onder Alpdogan, Stephanie J Muriglan, et al.
Transplantation|June 28, 2003
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantationOnder Alpdogan, Stephanie J Muriglan, Barry J Kappel, et al.
Frontiers in Oncology|February 7, 2022
Implementation of an Outpatient HD-MTX InitiativeKelsey Sokol, Kelley Yuan, Maria Piddoubny, et al.
Blood|September 26, 2008
Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantationS Onder Alpdogan, Sydney X Lu, Neel Patel, et al.
Leukemia & Lymphoma|November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Blood|November 18, 2005
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestineElisha Waldman, Sydney X Lu, Vanessa M Hubbard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell TransplantationSameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Transplantation and Cellular Therapy|September 27, 2022
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous TransplantationDolores Grosso, Benjamin Leiby, Lindsay Wilde, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Cell Transplantation|May 17, 2006
Molecular imaging reveals skeletal engraftment sites of transplanted bone marrow cellsPhilipp Mayer-Kuckuk, Mikhail Doubrovin, Luc Bidaut, et al.
Blood|March 31, 2007
Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activityChiara Borsotti, Anna R K Franklin, Sydney X Lu, et al.
Blood|November 9, 2002
Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantationCornelius Schmaltz, Onder Alpdogan, Stephanie J Muriglan, et al.
Transplantation|June 28, 2003
Insulin-like growth factor-I enhances lymphoid and myeloid reconstitution after allogeneic bone marrow transplantationOnder Alpdogan, Stephanie J Muriglan, Barry J Kappel, et al.
Frontiers in Oncology|February 7, 2022
Implementation of an Outpatient HD-MTX InitiativeKelsey Sokol, Kelley Yuan, Maria Piddoubny, et al.
Blood|September 26, 2008
Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantationS Onder Alpdogan, Sydney X Lu, Neel Patel, et al.
Leukemia & Lymphoma|November 4, 2020
Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphomaJonathan Pan, Sushil Ghimire, S Onder Alpdogan, et al.
Blood|November 18, 2005
Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestineElisha Waldman, Sydney X Lu, Vanessa M Hubbard, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2015
A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell TransplantationSameh Gaballa, Neil Palmisiano, Onder Alpdogan, et al.
Transplantation and Cellular Therapy|September 27, 2022
A Prospective, Randomized Trial Examining the Use of G-CSF Versus No G-CSF in Patients Post-Autologous TransplantationDolores Grosso, Benjamin Leiby, Lindsay Wilde, et al.
Pageof 9